Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia

Benzer Materyaller

• JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera
  Yazar:: Carobbio, Alessandra, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• An agenda for future research projects in polycythemia vera and essential thrombocythemia
  Yazar:: Barbui, Tiziano, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
  Yazar:: Lussana, Federico, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
  Yazar:: Barbui, Tiziano, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis
  Yazar:: Guglielmelli, Paola, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)